Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Changing the paradigm in frontline CML therapy

Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network

Changing the paradigm in frontline CML therapy ( Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network )

ENESTnd trial comparing nilotinib and imatinib as first line CML therapy

Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia

ENESTnd trial comparing nilotinib and imatinib as first line CML therapy ( Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia )

Haematological cancers in the elderly

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria

Haematological cancers in the elderly ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )

The importance of myelodysplastic syndrome diagnosis

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria

The importance of myelodysplastic syndrome diagnosis ( Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria )

Key lymphoma research from ASH 2010

Prof Wyndham Wilson - National Cancer Institute, Maryland, USA

Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )

The DASISION chronic myeloid leukaemia trial

Dr Neil Shah - University of California, San Francisco, USA

The DASISION chronic myeloid leukaemia trial ( Dr Neil Shah - University of California, San Francisco, USA )

CLL related research from ASH 2010

Dr Michael Keating- MD Anderson Cancer Center, Texas, USA

CLL related research from ASH 2010 ( Dr Michael Keating- MD Anderson Cancer Center, Texas, USA )

Key multiple myeloma research from ASH 2010

Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands

Key multiple myeloma research from ASH 2010 ( Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands )

The role of plasma cell biology in multiple myeloma

Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA

The role of plasma cell biology in multiple myeloma ( Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )

Advances in the treatment of CLL

Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA

Advances in the treatment of CLL ( Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA )

Key CML research from ASH 2010

Jan Geissler - Co-Founder, CML Advocates Network

Key CML research from ASH 2010 ( Jan Geissler - Co-Founder, CML Advocates Network )

Blood cancers in the elderly

Jan Geissler - Co-Founder, CML Advocates Network

Blood cancers in the elderly ( Jan Geissler - Co-Founder, CML Advocates Network )

More from ecancer